$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) – Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version, a federal judge ruled. The… Read More ›
Simvastatin
Statins block the ability of exercise to improve fitness levels
Cholesterol-Lowering Drug May Reduce Exercise Benefits for Obese Adults, MU Study Finds May 15, 2013 Story Contact(s): Jesslyn Chew, ChewJ@missouri.edu, (573) 882-8353 By Kate McIntyre COLUMBIA, Mo. – Statins, the most widely prescribed drugs worldwide, are often suggested to lower… Read More ›
Long-term effects of statin therapy could lead to transient or permanent cognitive impairment
2009 study posted for filing Contact: Nick Zagorski nzagorski@asbmb.org 301-634-7366 American Society for Biochemistry and Molecular Biology Statins show dramatic drug and cell dependent effects in the brain Besides their tremendous value in treating high cholesterol and lowering the risk… Read More ›
Cholesterol-lowering drug linked to sleep disruptions – Possibly promoting weight gain and insulin resistance
Cholesterol-lowering drug linked to sleep disruptions ORLANDO, Nov. 7 — A cholesterol-lowering drug appears to disrupt sleep patterns of some patients, researchers reported at the American Heart Association’s Scientific Sessions 2007. “The findings are significant because sleep problems… Read More ›
